[Pharmacology of sulfonium spasmolytics; modification of pharmacological properties following introduction into the molecule of alpha-hydroxyl group].
D002317:Cardiovascular Agents; D005260:Female; D006801:Humans; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D011247:Pregnancy
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics
MUSCLE RELAXANTS
Farmakologiia sul'fonievykh spazmolitikov; izmenenie farmakologicheskikh svoistv posle vvedeniia v molekuly al'fagidroksil'noi gruppy.